Synergy Biopharma P Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.70 M
- Company Age 31 Year, 14 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.60 M
About Synergy Biopharma P
Synergy Biopharma P Ltd (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 January 1994 and has a history of 31 years. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.70 M.
The company currently has active open charges totaling ₹1.60 M.
Dilip Mulay, Suraj Sharma, and Jaiprakash Bhat serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231MH1994PTC235075
-
Company No.
235075
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Jan 1994
-
Date of AGM
28 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Synergy Biopharma P Ltd offer?
Synergy Biopharma P Ltd offers a wide range of products and services, including Protein Powder, Chocolate Protein Powder, Industrial Clothing, Safety Suits, Door Mats, Rubber Door Mats, Face Mask & Medical PPE Kits, Cleanroom Clothing, Nutraceuticals, Protein Supplement.
Who are the key members and board of directors at Synergy Biopharma P?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suraj Sharma
|
Director | 01-Apr-1996 | Current |
|
Dilip Mulay
|
Director | 18-Jan-1994 | Current |
|
Jaiprakash Bhat
|
Director | 01-Nov-1998 | Current |
Financial Performance of Synergy Biopharma P.
Synergy Biopharma P Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synergy Biopharma P?
In 2017, Synergy Biopharma P had a promoter holding of 90.43% and a public holding of 9.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sr Products Private LimitedDilip Mulay is a mutual person
Charges (Loans)
₹1.60 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 0.16 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Feb 2015 | Bank Of Baroda | ₹1.60 M | Open |
How Many Employees Work at Synergy Biopharma P?
Synergy Biopharma P has a workforce of 1 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synergy Biopharma P, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synergy Biopharma P's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.